Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.75 -0.06 (-0.08%)
As of: Sep 29, 2026 · 3:59 PM EDT

Tarsus Pharmaceuticals (TARS) Total Current Liabilities (2019 - 2026)

Updated

Tarsus Pharmaceuticals' Total Current Liabilities came in at $175.75 million for Q2 2026, up 94.7% from $90.25 million a year earlier and up 22.5% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Tarsus Pharmaceuticals' Total Current Liabilities was $135.7 million, up 68.3% from FY2024.

  • Total Current Liabilities has increased in each of the last six years, with a five-year compound annual growth rate of 90.7% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $80.61 million in FY2024 (+118.2%), $36.94 million in FY2023 (+139.4%), $15.43 million in FY2022 (+34.4%) and $11.48 million in FY2021 (+113.1%).
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2019.
  • Year-over-year, Total Current Liabilities has increased for 20 consecutive quarters, with growth averaging 98.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Total Current Liabilities ranged from 5.1% (Q1 2023) to 249.3% (Q2 2024).
  • Business Quant data shows TARS's Total Current Liabilities at $143.51 million (Q1 2026), $135.7 million (Q4 2025) and $117.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn 175.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 175.75 Mn
Mar 31, 2026 143.51 Mn
Dec 31, 2025 135.70 Mn
Sep 30, 2025 117.05 Mn
Jun 30, 2025 90.25 Mn
Mar 31, 2025 86.31 Mn
Dec 31, 2024 80.61 Mn
Sep 30, 2024 65.87 Mn
Jun 30, 2024 51.57 Mn
Mar 31, 2024 42.53 Mn
Dec 31, 2023 36.94 Mn
Sep 30, 2023 23.25 Mn
Jun 30, 2023 14.77 Mn
Mar 31, 2023 13.26 Mn
Dec 31, 2022 15.43 Mn
Sep 30, 2022 14.27 Mn
Jun 30, 2022 11.72 Mn
Mar 31, 2022 12.61 Mn
Dec 31, 2021 11.48 Mn
Sep 30, 2021 10.37 Mn
API Access

Tarsus Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TARS&period=max&api_key=YOUR_API_KEY